Epidemiology from Literature | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2013 | Austria | IgE | 20 | 100.000 | 20130401, Berneder M
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Austria | IgE | 54 | 87.030 | 20090416, Gaier S
| 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 30.230 | 20101214, Gadisseur R
| 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 27.270 | 20091121, Ebo DG
| 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 65.000 | 20091121, Ebo DG
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 86.480 | 20090826, Ebo DG
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 64.650 | 20110223, De Knop KJ
| 1.3 - Rhinitis, Diagnosed | 2013 | Brazil | IgE | 101 | 0.900 | 20130912, Lacerda Araujo LM
| 3.2.1 - Source Sensitized (IgE) | 2013 | China | IgE | 49 | 20.400 | 20130624, Ma S
| 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2013 | China | IgE | 23 | 52.170 | 20130510, Ma S
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2013 | China | IgE | 38 | 47.400 | 20130624, Ma S
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | China | IgE | 56 | 5.360 | 20120903, Gao ZS
| 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 55.000 | 20091005, Ott H
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Italy | IgE | 21 | 4.760 | 20090808, Krause S
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2011 | Italy | IgE | 148 | 49.320 | 20110810, Pastorello EA
| 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Japan | IgE | 17 | 74.700 | 20090330, Asakura K
| 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 25.000 | 20131020, van Rhijn BD
| 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Netherlands | IgE | 211 | 57.300 | 20140331, Rockmann H
| 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2012 | Netherlands | IgE | 42 | 80.950 | 20120905, Le TM
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2009 | Portugal | IgE | 30 | 3.330 | 20081126, Rodrigus-Alves R
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2012 | Spain | IgE | 55 | 7.300 | 20120726, Pedrosa M
| 4.1.8 - Heterologous Source Sensitized (SPT, IgE) | 2012 | Spain | IgE | 68 | 11.800 | 20120726, Pedrosa M
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Spain | IgE | 53 | 11.320 | 20130319, Boyano-Martinez T
| 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 20.830 | 20120528, Patelis A
| 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 6.740 | 20120528, Patelis A
| 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 31.430 | 20130605, Simon D
|
|